Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
Expanding adoption of advanced biologics, small-molecule therapeutics, and targeted immunomodulators is significantly boosting market revenues. Additionally, the expected launch of therapies such as obefazimod (Abivax), tulisokibart (Merck), Afimkibart (RVT 3101) (Roche), MORF-057 (Eli Lilly), and others will further boost the market. LAS VEGAS Dec. 17, 2025 /PRNewswire/ -- DelveInsight's Ulcerative Colitis Market Insights report includes a comprehensive understanding of current treatment practices, ulcerative colitis emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into leading markets (the US, EU4, UK, and Japan). Ulcerative Colitis Market Summary The market size for ulcerative colitis in the leading markets is expected to grow significantly by 2034. The United States accounted for the highest ulcerative colitis treatment market size in 7MM in 2024, in comparison to the other major markets, i.e., EU4 co
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilitiesPR Newswire
- Calluna Pharma Announces the Appointment of Gijs van den Brink, MD, PhD, as Independent Director [Yahoo! Finance]Yahoo! Finance
- Manifold Bio Expands Leadership Team to Drive its AI + In Vivo Targeted Biologics Platform [Yahoo! Finance]Yahoo! Finance
- Zealand Pharma and OTR to develop metabolic disease therapeutics [Yahoo! Finance]Yahoo! Finance
- FDA proposes allowing sunscreen ingredient already used in Europe and Asia [MSNBC.com]MSNBC.com